Lack of effect of different pain-related manipulations on opioid self-administration, reinstatement of opioid seeking, and opioid choice in rats.


Journal

Psychopharmacology
ISSN: 1432-2072
Titre abrégé: Psychopharmacology (Berl)
Pays: Germany
ID NLM: 7608025

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 12 02 2021
accepted: 01 03 2021
pubmed: 26 3 2021
medline: 6 7 2021
entrez: 25 3 2021
Statut: ppublish

Résumé

Pain-related factors increase the risk for opioid addiction, and pain may function as a negative reinforcer to increase opioid taking and seeking. However, experimental pain-related manipulations generally do not increase opioid self-administration in rodents. This discrepancy may reflect insufficient learning of pain-relief contingencies or confounding effects of pain-related behavioral impairments. Here, we determined if pairing noxious stimuli with opioid self-administration would promote pain-related reinstatement of opioid seeking or increase opioid choice over food. In Experiment 1, rats self-administered fentanyl in the presence or absence of repeated intraplantar capsaicin injections in distinct contexts to model context-specific exposure to cutaneous nociception. After capsaicin-free extinction in both contexts, we tested if capsaicin would reinstate fentanyl seeking. In Experiment 2, rats self-administered heroin after intraperitoneal (i.p.) lactic acid injections to model acute visceral inflammatory pain. After lactic acid-free extinction, we tested if lactic acid would reinstate heroin seeking. In Experiment 3, we tested if repeated i.p. lactic acid or intraplantar Complete Freund's Adjuvant (CFA; to model sustained inflammatory pain) would increase fentanyl choice over food. In Experiments 1-2, neither capsaicin nor lactic acid reinstated opioid seeking after extinction, and lactic acid did not increase heroin-induced reinstatement. In Experiment 3, lactic acid and CFA decreased reinforcement rate without affecting fentanyl choice. Results extend the range of conditions across which pain-related manipulations fail to increase opioid seeking in rats and suggest that enhanced opioid-addiction risk in humans with chronic pain involves factors other than enhanced opioid reinforcement and relapse.

Identifiants

pubmed: 33765177
doi: 10.1007/s00213-021-05816-9
pii: 10.1007/s00213-021-05816-9
pmc: PMC10041878
mid: NIHMS1881147
doi:

Substances chimiques

Analgesics, Opioid 0
Fentanyl UF599785JZ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1885-1897

Subventions

Organisme : NIGMS NIH HHS
ID : 1FI2GM128603
Pays : United States
Organisme : NIDA NIH HHS
ID : P30 DA033934
Pays : United States
Organisme : NIDA NIH HHS
ID : P30DA0333034
Pays : United States
Organisme : NIDA NIH HHS
ID : F32DA047026
Pays : United States
Organisme : NIDA NIH HHS
ID : Funds of Intramural Research Program
Pays : United States

Références

Subst Abus. 2012;33(4):361-5
pubmed: 22989279
Pain. 2001 Mar;91(1-2):33-45
pubmed: 11240076
Pain Physician. 2017 Feb;20(2S):S93-S109
pubmed: 28226333
J Neurosci. 2015 Sep 02;35(35):12217-31
pubmed: 26338332
Pharmacol Biochem Behav. 1988 Oct;31(2):445-51
pubmed: 3244721
Drug Alcohol Depend. 2020 Apr 1;209:107902
pubmed: 32088587
PLoS One. 2016 Feb 25;11(2):e0150164
pubmed: 26915030
Clin J Pain. 2009 Mar-Apr;25(3):193-8
pubmed: 19333168
J Pain. 2002 Aug;3(4):309-19
pubmed: 14622755
Drug Alcohol Depend. 2019 Nov 1;204:107501
pubmed: 31479865
Neuropsychopharmacology. 2016 Jan;41(1):335-56
pubmed: 25976297
JAMA. 2003 May 14;289(18):2370-8
pubmed: 12746360
Mol Pain. 2014 Sep 23;10:62
pubmed: 25245060
Psychopharmacology (Berl). 2003 Jul;168(1-2):3-20
pubmed: 12402102
Psychopharmacology (Berl). 2020 Jul;237(7):2201-2212
pubmed: 32382785
Neuropsychopharmacology. 1996 Jun;14(6):375-424
pubmed: 8726752
J Pharmacol Exp Ther. 2015 Feb;352(2):208-17
pubmed: 25406170
J Pain. 2005 Dec;6(12):798-808
pubmed: 16326368
Neuropsychopharmacology. 2019 Nov;44(12):2022-2029
pubmed: 30818323
J Med Toxicol. 2012 Dec;8(4):393-9
pubmed: 23073725
Neuropharmacology. 2021 Mar 15;186:108476
pubmed: 33524407
Drug Alcohol Depend. 1980 Sep;6(3):163-73
pubmed: 6107237
Life Sci. 1989;45(23):2217-24
pubmed: 2601574
J Subst Abuse Treat. 2017 Jun;77:26-30
pubmed: 28476267
Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3233-43
pubmed: 18640922
PLoS One. 2013 Nov 15;8(11):e79239
pubmed: 24260176
Neurology. 2007 Apr 10;68(15):1178-82
pubmed: 17420400
Neurosci Lett. 2016 Oct 6;632:44-9
pubmed: 27544012
Behav Brain Res. 2006 Jun 30;170(2):308-15
pubmed: 16675039
Front Pharmacol. 2021 Jan 29;11:615782
pubmed: 33584295
Nat Rev Neurosci. 2020 Nov;21(11):625-643
pubmed: 33024318
Pharmacol Biochem Behav. 2011 Mar;98(1):35-42
pubmed: 21147151
Nat Methods. 2010 Jun;7(6):447-9
pubmed: 20453868
Pain Res Manag. 2011 May-Jun;16(3):169-77
pubmed: 21766066
ACS Chem Neurosci. 2020 May 6;11(9):1300-1310
pubmed: 32271538
Brain Res Brain Res Rev. 2000 Aug;33(1):13-33
pubmed: 10967352
Neuropharmacology. 2019 Dec 1;160:107689
pubmed: 31271771
Pain. 1996 Sep;67(1):179-188
pubmed: 8895246
Prog Brain Res. 2010;186:141-57
pubmed: 21094890
Eur J Pain. 2012 Apr;16(4):485-95
pubmed: 22396078
Adv Pharmacol Sci. 2012;2012:281768
pubmed: 23243420
Pain Physician. 2017 Feb;20(2S):S111-S133
pubmed: 28226334
J Subst Abuse Treat. 2014 Aug;47(2):140-5
pubmed: 24814051
Psychopharmacology (Berl). 2018 May;235(5):1609-1618
pubmed: 29572653
Psychopharmacology (Berl). 1980;70(2):213-7
pubmed: 6776582
Nature. 1983 Mar 17-23;302(5905):251-3
pubmed: 6188055
J Pharmacol Exp Ther. 2012 Nov;343(2):389-400
pubmed: 22892341
Behav Neurosci. 2002 Feb;116(1):169-73
pubmed: 11895178
Neuropsychopharmacology. 2019 Sep;44(10):1681-1689
pubmed: 31043682
Lab Anim (NY). 2013 Aug;42(8):292-300
pubmed: 23877610
Neuropsychopharmacology. 2015 Jan;40(2):421-8
pubmed: 25060491
Neuropharmacology. 2019 May 15;150:200-209
pubmed: 30660628
Behav Pharmacol. 2021 Apr 1;32(2&3):142-152
pubmed: 33079736
Trends Pharmacol Sci. 2017 Feb;38(2):181-194
pubmed: 27916279
J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S80-6
pubmed: 20307799
Life Sci. 1982 Jul 5;31(1):67-75
pubmed: 7109855
Pharmacol Rev. 2019 Apr;71(2):225-266
pubmed: 30898855
Sci Signal. 2016 Nov 29;9(456):ra117
pubmed: 27899527
Prog Neurobiol. 2011 Mar;93(3):385-404
pubmed: 21216272
Pain. 2008 Sep 30;139(1):127-135
pubmed: 18455314
Pain. 2009 Jul;144(1-2):170-7
pubmed: 19435650
Psychopharmacology (Berl). 2020 Nov;237(11):3369-3381
pubmed: 32990768
Anesthesiology. 2007 Feb;106(2):312-22
pubmed: 17264726
Pain. 1992 Apr;49(1):129-135
pubmed: 1594274
J Pharmacol Exp Ther. 1977 Sep;202(3):660-9
pubmed: 19619
J Pain. 2012 Feb;13(2):146-54
pubmed: 22245713
Exp Clin Psychopharmacol. 2008 Oct;16(5):357-66
pubmed: 18837632
Pain. 2006 Sep;124(1-2):34-49
pubmed: 16650579
MMWR Morb Mortal Wkly Rep. 2018 Sep 14;67(36):1001-1006
pubmed: 30212442
Mol Pain. 2011 Jul 29;7:55
pubmed: 21801409
Trends Pharmacol Sci. 2018 Nov;39(11):911-916
pubmed: 30343726
Exp Clin Psychopharmacol. 2015 Oct;23(5):405-14
pubmed: 26375515
Anesthesiology. 2004 Jul;101(1):191-203
pubmed: 15220791

Auteurs

David J Reiner (DJ)

Behavioral Neuroscience Branch, IRP/NIDA/NIH, Baltimore, MD, USA. david.reiner@nih.gov.
NIGMS, Bethesda, MD, USA. david.reiner@nih.gov.

E Andrew Townsend (EA)

Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.

Javier Orihuel (J)

Behavioral Neuroscience Branch, IRP/NIDA/NIH, Baltimore, MD, USA.

Sarah V Applebey (SV)

Behavioral Neuroscience Branch, IRP/NIDA/NIH, Baltimore, MD, USA.

Sarah M Claypool (SM)

Behavioral Neuroscience Branch, IRP/NIDA/NIH, Baltimore, MD, USA.

Matthew L Banks (ML)

Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.

Yavin Shaham (Y)

Behavioral Neuroscience Branch, IRP/NIDA/NIH, Baltimore, MD, USA.

S Stevens Negus (SS)

Department of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, USA. sidney.negus@vcuhealth.org.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH